Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health

DUBLIN, May 15, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it will showcase data during the upcoming American Psychiatric Association (APA) Annual Meeting in San Francisco, May 18 – May 22, 2019. Data being presented include…

Source: prnewswire
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health